Ciprofloxacin
Sold as Ciprobay, Ciprofloxacin pharma q, Cifran, Biocip, Simayla ciprofloxacin, Cifloc, Cilofloc, Dynafloc, Orpic, Ciloxan eye, Cipro unimed, Ciploxx, Ciprogen, Ciprofloxacin actor, Ciprobay xr, Ciploxx iv, Ciploxx-iv, Ciprofloxacin austell, Ciprol, Ciprofloxacin iv cospharm, SPEC ciprofloxacin, Merck-ciprofloxcin iv, Gulf ciprofloxacin, Loxip, Mylan ciprofloxacin, Adco ciprofloxacin, Ciprofloxacin unicorn, Profloxin, Foxin, Flopro, Coliprid, Ciprofloxacin ( ) fresenius, Ciprofloxacin dezzo iv, Profloxin iv, Floqin iv, Apex ciprofloxacin, Ciprodac, Ciprochem, Camox-ciprofloxacin, Ciprofloxacin-safeline, Ceprolen eye, Zoxan eye, Ciprocina, Bio-ciprofloxacin, Biofloxx, *Ciprofloxacin iv cospharm, Orpic iv, Ciprogen iv, Ciprobay iv
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
Drag to rotate. Structure from PubChem CID 2764.
Background
Registration
- Applicants
- 30
- Registrations
- 98
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Bayer (Pty) Ltd û IsandoCertificate held by Bayer (Pty) Ltd4 of 7 cancelled | Ciprobay, Ciprobay xr, Ciprobay iv | 5 %, 100 mg, 200 mg, 250, 400 mg, 500, 750, 1000 | 310111, 370250, 380024, U0126, U0127, U0128, Y0311 | S4 | PIPIL |
| Pharma-q Holdings (Pty) Ltd | Ciprofloxacin pharma q | 250, 500 | 320118, 320119 | S4 | None |
| Ranbaxy Pharmaceutical (Pty) Ltd2 of 4 cancelled | Cifran, Biocip | 250, 500 | 330365, 330366, 330368, 330369 | S4 | None |
| Ranbaxy (SA) (Pty) Ltd | Simayla ciprofloxacin | 250 mg, 500 mg | 330371, 330372 | S4 | None |
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd. | Cifloc | 250, 500, 750 | 340308, 340309, 340310 | S4 | PI |
| Be-tabs Pharmaceuticals (Pty) LtdCancelled | Cilofloc | 250, 500, 750 | 340312, 340313, 340314 | S4 | None |
| Pharma Dynamics (Pty) Ltd | Dynafloc | 500 mg | 340405 | S4 | PIPIL |
| Acino Pharma (Pty) LtdCancelled | Orpic, Orpic iv | 2 mg/ml, 250 mg, 500 mg, 750 mg | 350101, 350102, 350103, A400454 | S4 | None |
| Novartis South Africa (Pty) Ltd | Ciloxan eye | 3 mg/ml, drops | 350410, Z0202 | S4 | PIPIL |
| Unimed Healthcare (Pty) Ltd | Cipro unimed, Ciprol, Flopro, Ciprodac | 250 mg, 500 mg, 750 mg | 360170, 360171, 360172, 370573, 370574, 370575, 450198, 450199, 450200, A380715 | S4 | PIPIL |
| Cipla Medpro (Pty) Ltd3 of 7 cancelled | Ciploxx, Ciprofloxacin actor, Ciploxx iv, Ciploxx-iv | 100, 200, 250mg / 500mg, 250, 500 | 360376, 360377, 360378, 370079, 370080, 370294, 370295 | S4 | PIPIL |
| Trinity Pharma (Pty) Ltd | Ciprogen | 250 mg, 500 mg, 750 mg | 360427, 360428, 360429 | S4 | None |
| Austell Pharmaceuticals (Pty) LtdCertificate held by Austell Laboratories (Pty) Ltd2 of 6 cancelled | Ciprofloxacin austell, Floqin iv, Ciprochem | 2 mg/mL, 250 MG, 500 MG, 750 MG | 370354, 380011, 380012, 501035, A390044, A390045 | S4 | PIPIL |
| Cospharm Investments (Pty) Ltd | Ciprofloxacin iv cospharm, *Ciprofloxacin iv cospharm | 200, 400 | 370655, A400390 | S4 | None |
| Specpharm (Pty) Ltd | SPEC ciprofloxacin | Not stated | 380191 | S4 | None |
| Viatris South Africa (Pty) Ltd | Merck-ciprofloxcin iv, Ciprogen iv | Not stated | 410390, A400618 | S4 | None |
| Gulf Drug Company (Pty) Ltd1 of 3 cancelled | Gulf ciprofloxacin, Foxin | 250, 500 | 410974, 410975, 450034 | S4 | None |
| Aurogen South Africa (Pty) Ltd1 of 5 cancelled | Loxip, Coliprid | 250 mg, 500 mg, 750 mg | 411052, 411053, 450201, 450202, 450203 | S4 | None |
| Viatris Healthcare (Pty) Ltd | Mylan ciprofloxacin | 200 mg/100 ml, 400 mg/200 ml | 430955, 430956 | S4 | None |
| Adcock ingram limitedCancelled | Adco ciprofloxacin | 2 mg/ml | 431025 | S4 | None |
| Ascendis Pharma (Pty) Ltd | Ciprofloxacin unicorn, Profloxin iv, Ciprocina | 250, 500, 750 | 440538, 440539, 440540, 471286, A400114 | S4 | None |
| Dezzo Trading 392 (Pty) Ltd | Profloxin, Ciprofloxacin dezzo iv | 250, 500, 750 | 440541, 440542, 440543, 471285 | S4 | None |
| Fresenius Kabi South Africa (Pty) Ltd | Ciprofloxacin ( ) fresenius | 2 mg/mL, 2 mg/mL, 2 mg/mL, 2 mg/ml 100 ml, 2 mg/ml 200 ml | 450797, 450798, 450799 | S4 | PIPIL |
| Camox Pharmaceuticals (Pty) LtdCancelled | Apex ciprofloxacin, Camox-ciprofloxacin | 250 mg, 500 mg, 750 mg | A380448, A380449, A380450, A390046 | S4 | None |
| Safeline Pharmaceuticals (Pty) LtdCancelled | Ciprofloxacin-safeline | 100, 200, 400 | A390334, A390335, A390336 | S4 | None |
| Adcock Ingram Critical Care (Pty) Ltd | Adco ciprofloxacin | 2 mg/ML | A390646 | S4 | None |
| Epiglo Pharmaceuticals (Pty) Ltd | Ceprolen eye | drops | A400048 | S4 | None |
| FDC SA (Pty) Ltd | Zoxan eye | 0.3% w/v | A400091 | S4 | PIPIL |
| Biotech Laboratories (Pty) Ltd | Bio-ciprofloxacin | 250, 500, 750 | A400368, A400369, A400370 | S4 | None |
| Arya Pharma (Pty) Ltd | Biofloxx | 250, 500, 750 | A400371, A400372, A400373 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ciprobay suspension 5 % EACH 50 ml SUSPENSION CONTAINS CIPROFLOXACIN 2,5 g | 5 %Suspension | 31011131/20.1.1/0111 | Registered | S4 | None |
| Ciprofloxacin 250 pharma q EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | 32011832/20.1.1/0118 | Registered | S4 | None |
| Ciprofloxacin 500 pharma q EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | 32011932/20.1.1/0119 | Registered | S4 | None |
| Cifran 250 tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250Tablets | 33036533/20.1.1/0365 | Registered | S4 | None |
| Cifran 500 tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500Tablets | 33036633/20.1.1/0366 | Registered | S4 | None |
| Biocip 250 tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250Tablets | 33036833/20.1.1/0368 | Cancelled | S4 | None |
| Biocip 500 tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500Tablets | 33036933/20.1.1/0369 | Cancelled | S4 | None |
| Simayla ciprofloxacin 250 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mg | 33037133/20.1.1/0371 | Registered | S4 | None |
| Simayla ciprofloxacin 500 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mg | 33037233/20.1.1/0372 | Registered | S4 | None |
| Cifloc 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250Film-coated tablets | 34030834/20.1.1/0308Approved 26 July 2020 | Registered | S4 | PI |
| Cifloc 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500Film-coated tablets | 34030934/20.1.1/0309Approved 26 July 2020 | Registered | S4 | PI |
| Cifloc 750 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750Film-coated tablets | 34031034/20.1.1/0310Approved 26 July 2020 | Registered | S4 | PI |
| Cilofloc 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | 34031234/20.1.1/0312 | Cancelled | S4 | None |
| Cilofloc 500 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | 34031334/20.1.1/0313 | Cancelled | S4 | None |
| Cilofloc 750 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 | 34031434/20.1.1/0314 | Cancelled | S4 | None |
| Dynafloc 500 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mgTablets. | 34040534/20.1.1/0405Approved 19 September 2025 | Registered | S4 | PIPIL |
| Orpic 250 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mgTablets | 35010135/20.1.1/0101 | Cancelled | S4 | None |
| Orpic 500 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mgTablets | 35010235/20.1.1/0102 | Cancelled | S4 | None |
| Orpic 750 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 mgTablets | 35010335/20.1.1/0103 | Cancelled | S4 | None |
| Ciloxan eye ointment EACH 1,0 g OINTMENT CONTAINS CIPROFLOXACIN HYDROCHLORIDE E EQUIVALENT TO CIPROFLOXACIN 3,0 mg | 3 mg/mlEye drops: colourless, clear solution | 35041035/15.1/0410Approved 30 November 2021 | Registered | S4 | PIPIL |
| Cipro 250 unimed EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250Film-coated tablets | 36017036/20.1.1/0170Approved 28 May 2024 | Registered | S4 | PIPIL |
| Cipro 500 unimed EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500Film-coated tablets | 36017136/20.1.1/0171Approved 28 May 2024 | Registered | S4 | PIPIL |
| Cipro 750 unimed EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750Film-coated tablets | 36017236/20.1.1/0172Approved 28 May 2024 | Registered | S4 | PIPIL |
| Ciploxx 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250mg / 500mgTablets | 36037636/20.1.1/0376Approved 21 November 2025 | Registered | S4 | PIPIL |
| Ciploxx 500 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 250mg / 500mgTablets | 36037736/20.1.1/0377Approved 21 November 2025 | Registered | S4 | PIPIL |
| Ciploxx 750 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 250mg / 500mgTablets | 36037836/20.1.1/0378Approved 21 November 2025 | Cancelled | S4 | PIPIL |
| Ciprogen 750 MG EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 mg | 36042736/20.1.1/0427 | Registered | S4 | None |
| Ciprogen 250 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mg | 36042836/20.1.1/0428 | Registered | S4 | None |
| Ciprogen 500 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mg | 36042936/20.1.1/0429 | Registered | S4 | None |
| Ciprofloxacin actor 250 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TOIPROFLOXACIN 250,0 mg | 250 | 37007937/20.1.1/0079 | Registered | S4 | None |
| Ciprofloxacin actor 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | 37008037/20.1.1/0080 | Registered | S4 | None |
| Ciprobay xr 500 EACH TABLET CONTAINS CIPROFLOXACIN 500,0 mg | 500 | 37025037/20.1.1/0250 | Cancelled | S4 | None |
| Ciploxx iv 100 EACH 10,0 ml AMPOULE CONTAINS CIPROFLOXACIN 100,0 mg | 100 | 37029437/20.1.1/0294 | Cancelled | S4 | None |
| Ciploxx-iv 200 EACH VIAL CONTAINS CIPROFLOXACIN 200,0 mg | 200 | 37029537/20.1.1/0295 | Cancelled | S4 | None |
| Ciprofloxacin 750 MG austell EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 MG | 37035437/20.1.1/0354 | Registered | S4 | None |
| Ciprol 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | 37057337/20.1.1/0573 | Registered | S4 | None |
| Ciprol 500 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | 37057437/20.1.1/0574 | Registered | S4 | None |
| Ciprol 750 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 | 37057537/20.1.1/0575 | Registered | S4 | None |
| Ciprofloxacin 200 iv cospharm EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | 200 | 37065537/20.1.1/0655 | Registered | S4 | None |
| Ciprofloxacin 250 MG austell EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 MG | 38001138/20.1.1/0011 | Registered | S4 | None |
| Ciprofloxacin 500 MG austell EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 MG | 38001238/20.1.1/0012 | Registered | S4 | None |
| Ciprobay xr 1000 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 1000,0 mg | 1000 | 38002438/20.1.1/0024 | Cancelled | S4 | None |
| SPEC ciprofloxacin EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | Not listed | 38019138/20.1.1/0191 | Registered | S4 | None |
| Merck-ciprofloxcin iv EACH 100,0 ml SOLUTION CONTAINS CIPROFLOXACIN 200,0 mg | Not listed | 41039041/20.1.1/0390 | Registered | S4 | None |
| Gulf ciprofloxacin 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | 41097441/20.1.1/0974 | Registered | S4 | None |
| Gulf ciprofloxacin 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | 41097541/20.1.1/0975 | Registered | S4 | None |
| Loxip 250 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mg | 41105241/20.1.1/1052 | Registered | S4 | None |
| Loxip 500 MG EACH TABLET CONTAINS;CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mg | 41105341/20.1.1/1053 | Registered | S4 | None |
| Mylan ciprofloxacin 200 mg/100 ML EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN 2,0 mg | 200 mg/100 ml | 43095543/20.1.1/0955 | Registered | S4 | None |
| Mylan ciprofloxacin 400 mg/200 ML EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN 2,0 mg | 400 mg/200 ml | 43095643/20.1.1/0956 | Registered | S4 | None |
| Adco ciprofloxacin 2 mg/ml infusion EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN 2,0 mg | 2 mg/mlInfusion | 43102543/20.1.1/1025 | Cancelled | S4 | None |
| Ciprofloxacin unicorn 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | 44053844/20.1.1/0538 | Registered | S4 | None |
| Ciprofloxacin unicorn 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | 44053944/20.1.1/0539 | Registered | S4 | None |
| Ciprofloxacin unicorn 750 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 | 44054044/20.1.1/0540 | Registered | S4 | None |
| Profloxin 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | 44054144/20.1.1/0541 | Registered | S4 | None |
| Profloxin 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | 44054244/20.1.1/0542 | Registered | S4 | None |
| Profloxin 750 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 | 44054344/20.1.1/0543 | Registered | S4 | None |
| Foxin EACH 1,0 ml EYE DROPS CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 3,0 mg | Not listed | 45003445/15.1/0034 | Cancelled | S4 | None |
| Flopro 250 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mgTablets | 45019845/20.1.1/0198 | Registered | S4 | None |
| Flopro 500 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mgTablets | 45019945/20.1.1/0199 | Registered | S4 | None |
| Flopro 750 MG tablets EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 mgTablets | 45020045/20.1.1/0200 | Registered | S4 | None |
| Coliprid 250 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mgTablets | 45020145/20.1.1/0201 | Registered | S4 | None |
| Coliprid 500 MG tablets EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mgTablets | 45020245/20.1.1/0202 | Registered | S4 | None |
| Coliprid 750 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 mgTablets | 45020345/20.1.1/0203 | Cancelled | S4 | None |
| Ciprofloxacin 2 mg/ml (50 ml) fresenius EACH 50,0 ml CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 100,0 mg | 2 mg/mL, 2 mg/mL, 2 mg/mLSolution for infusion. | 45079745/20.1.1/0797Approved 11 October 2023 | Registered | S4 | PIPIL |
| Ciprofloxacin 2 mg/ml (100 ml) fresenius EACH 100,0 ml CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 200,0 mg | 2 mg/ml 100 ml | 45079845/20.1.1/0798 | Registered | S4 | None |
| Ciprofloxacin 2 mg/ml (200 ml) fresenius EACH 250,0 ml CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 2 mg/ml 200 ml | 45079945/20.1.1/0799 | Registered | S4 | None |
| Ciprofloxacin dezzo iv EACH 1,0 ml SOLUTION CONTAINS : CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | Not listed | 47128547/20.1.1/1285 | Registered | S4 | None |
| Profloxin iv EACH 1,0 ml SOLUTION CONTAINS : CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | Not listed | 47128647/20.1.1/1286 | Registered | S4 | None |
| Floqin iv 2 mg/ml EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | 2 mg/mLSolution for infusion | 50103550/20.1.1/1035Approved 4 August 2020 | Registered | S4 | PIPIL |
| Apex ciprofloxacin 250 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mgTablets | A380448A38/20.1.1/0448 | Cancelled | S4 | None |
| Apex ciprofloxacin 500 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mgTablets | A380449A38/20.1.1/0449 | Cancelled | S4 | None |
| Apex ciprofloxacin 750 MG tablets EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 mgTablets | A380450A38/20.1.1/0450 | Cancelled | S4 | None |
| Ciprodac 500 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | A380715A38/20.1.1/0715 | Registered | S4 | None |
| Ciprochem 250 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 mg | A390044A39/20.1.1/0044 | Cancelled | S4 | None |
| Ciprochem 500 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 mg | A390045A39/20.1.1/0045 | Cancelled | S4 | None |
| Camox-ciprofloxacin 750 MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 mg | A390046A39/20.1.1/0046 | Cancelled | S4 | None |
| Ciprofloxacin-safeline 100 EACH 50,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 100,0 mg | 100 | A390334A39/20.1.1/0334 | Cancelled | S4 | None |
| Ciprofloxacin-safeline 200 EACH 100,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 200,0 mg | 200 | A390335A39/20.1.1/0335 | Cancelled | S4 | None |
| Ciprofloxacin-safeline 400 EACH 200,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 400,0 mg | 400 | A390336A39/20.1.1/0336 | Cancelled | S4 | None |
| Adco ciprofloxacin 2 mg/ml EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | 2 mg/ML | A390646A39/20.1.1/0646 | Registered | S4 | None |
| Ceprolen eye drops EACH 1,00 ml SOLUTION CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 0,30 g | Drops | A400048A40/15.1/0048 | Registered | S4 | None |
| Zoxan eye drops EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 3,0 mg | 0.3% w/vEye drops: | A400091A40/15.1/0091Approved 14 June 2023 | Registered | S4 | PIPIL |
| Ciprocina EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | Not listed | A400114A40/20.1.1/0114 | Registered | S4 | None |
| Bio-ciprofloxacin 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | A400368A40/20.1.1/0368 | Registered | S4 | None |
| Bio-ciprofloxacin 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | A400369A40/20.1.1/0369 | Registered | S4 | None |
| Bio-ciprofloxacin 750 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 | A400370A40/20.1.1/0370 | Registered | S4 | None |
| Biofloxx 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | A400371A40/20.1.1/0371 | Registered | S4 | None |
| Biofloxx 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | A400372A40/20.1.1/0372 | Registered | S4 | None |
| Biofloxx 750 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 | A400373A40/20.1.1/0373 | Registered | S4 | None |
| *Ciprofloxacin 400 iv cospharm EACH 1,0 ml SOLUTION CONTAINS: CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | 400 | A400390A40/20.1.1/0390 | Registered | S4 | None |
| Orpic 2 mg/ml iv EACH 1,0 ml SOLUTION CONTAINS CIPROFLOXACIN LACTATE EQUIVALENT TO CIPROFLOXACIN 2,0 mg | 2 mg/ml | A400454A40/20.1.1/0454 | Cancelled | S4 | None |
| Ciprogen iv EACH 100,0 ml SOLUTION CONTAINS CIPROFLOXACIN 200,0 mg | Not listed | A400618A40/20.1.1/0618 | Registered | S4 | None |
| Ciprobay 250 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO CIPROFLOXACIN 250,0 mg | 250 | U0126U/20.1.1/126 | Cancelled | S4 | None |
| Ciprobay 500 EACH TABLET CONTAINS:CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE EQUIVALENT TO CIPROFLOXACIN 500,0 mg | 500 | U0127U/20.1.1/127 | Registered | S4 | None |
| Ciprobay 750 EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACIN 750,0 mg | 750 | U0128U/20.1.1/128 | Cancelled | S4 | None |
| Ciprobay iv EACH 50 ml INFUSION SOLUTION CONTAINS CIPROFLOXACIN 100 mg | 100 mg. 200 mg. 400 mgSolution for infusion | Y0311Y/20.1.1/311Approved 14 January 2025 | Registered | S4 | PIPIL |
| Ciloxan eye drops EACH 1 ml SOLUTION CONTAINS CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO 3 g CIPROFLOXACIN | Drops | Z0202Z/15.1/202 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Ciprofloxacin
S4: Ciprofloxacin
Consolidated Schedules 06 July 2026, line 5815
Pharmacological class: Broad and medium spectrum antibiotics. (class 20.1.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.